Viva Biotech Holdings (OTCMKTS:VBIZF) Short Interest Up 355.8% in August

Viva Biotech Holdings (OTCMKTS:VBIZF) was the recipient of a large growth in short interest in August. As of August 31st, there was short interest totaling 638,598 shares, a growth of 355.8% from the August 15th total of 140,098 shares. Based on an average daily trading volume, of 109 shares, the days-to-cover ratio is presently 5,858.7 days.

Viva Biotech Stock Performance

Shares of Viva Biotech stock opened at $0.19 on Friday. Viva Biotech has a 1-year low of $0.13 and a 1-year high of $0.20. The business has a 50-day moving average of $0.17 and a 200-day moving average of $0.24.

About Viva Biotech

Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.

With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.